Skip to Content

New Additions to Drugs.com for 2020

We update the Drugs.com database on a regular cycle. The following new drug information was added in 2020:

Gimoti
Jul 1, 2020 - Gimoti (metoclopramide) is a prescription medicine used for the relief of symptoms of acute and recurrent diabetic gastroparesis in adults.

Dojolvi
Jun 30, 2020 - Dojolvi (triheptanoin) is a prescription medicine indicated as a source of calories and fatty acids for the treatment of patients with long-chain fatty acid oxidation disorders (LC-FAOD).

Mycapssa
Jun 30, 2020 - Mycapssa (octreotide) is an oral somatostatin analog for the treatment of acromegaly.

Fintepla
Jun 28, 2020 - Fintepla (fenfluramine) is an amphetamine derivative indicated for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older.

Uplizna
Jun 25, 2020 - Uplizna (inebilizumab-cdon) is a CD19-directed cytolytic antibody indicated for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive.

Oriahnn
Jun 24, 2020 - Oriahnn (elagolix/estradiol/norethindrone acetate and elagolix) is a gonadotropin-releasing hormone (GnRH) receptor antagonist, estrogen and progestin co-formulation indicated for the management of heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women.

Zepzelca
Jun 16, 2020 - Zepzelca (lurbinectedin) is a selective oncogenic transcription inhibitor indicated for the treatment of adult patients with metastatic small cell lung cancer (SCLC).

Qinlock
May 27, 2020 - Qinlock (ripretinib) is a prescription medicine for the treatment of patients with advanced gastrointestinal stromal tumor (GIST).

Retevmo
May 25, 2020 - Retevmo (selpercatinib) is a prescription medicine used in the treatment of non-small cell lung cancer (NSCLC) and thyroid cancer.

Tabrecta
May 6, 2020 - Tabrecta (capmatinib) is a kinase inhibitor indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) with METex14.

Ongentys
Apr 28, 2020 - Ongentys (opicapone) is a prescription medicine used with levodopa/carbidopa in Parkinson’s disease (PD) patients who experience “off” episodes.

Trodelvy
Apr 25, 2020 - Trodelvy (sacituzumab govitecan-hziy) is a prescription medicine for the treatment of patients with previously-treated metastatic triple-negative breast cancer (mTNBC).

Tukysa
Apr 18, 2020 - Tukysa (tucatinib) is a prescription medicine used in combination with trastuzumab and capecitabine for the treatment of patients with advanced unresectable or metastatic HER2-positive breast cancer.

Koselugo
Apr 14, 2020 - Koselugo (selumetinib) is a prescription medicine used for the treatment of pediatric patients with neurofibromatosis type 1 (NF1).

Nexlizet
Apr 6, 2020 - Nexlizet (bempedoic acid and ezetimibe) is a prescription medicine containing two cholesterol lowering medicines. Nexlizet is used to treat patients with heterozygous familial hypercholesterolemia or known heart disease in patients who require additional lowering of low density lipoprotein (LDL).

Nurtec ODT
Apr 5, 2020 - Nurtec ODT (rimegepant) is a calcitonin gene-related peptide (CGRP) receptor antagonist for the acute treatment of migraine.

Isturisa
Mar 31, 2020 - Isturisa (osilodrostat) is a prescription medicine indicated for the treatment of adult patients with Cushing’s disease.

Sarclisa
Mar 31, 2020 - Sarclisa (isatuximab-irfc) is a prescription medicine used in combination with pomalidomide and dexamethasone for the treatment of adult patients multiple myeloma.

Zeposia
Mar 29, 2020 - Zeposia (ozanimod) is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS).

Vyepti
Mar 22, 2020 - Vyepti (eptinezumab-jjmr) is a calcitonin gene-related peptide antagonist indicated for the preventive treatment of migraine in adults.

Nexletol
Feb 29, 2020 - Nexletol (bempedoic acid) is used to LDL-cholesterol in adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease.

Twirla
Feb 24, 2020 - Twirla (ethinyl estradiol and levonorgestrel transdermal system) is a low-dose combined hormonal contraceptive patch for birth control.

Monoferric
Feb 13, 2020 - Monoferric (ferric derisomaltose) is an intravenous iron replacement product indicated for the treatment of iron deficiency anemia.

Valtoco Nasal Spray
Feb 11, 2020 - Valtoco (diazepam) is a benzodiazepine nasal spray for the short-term treatment of epilepsy cluster seizures.

Palforzia
Feb 4, 2020 - Palforzia (Peanut (Arachis hypogaea) Allergen Powder-dnfp) is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanut.

Trijardy XR
Jan 28, 2020 - Trijardy XR (empagliflozin/linagliptin/metformin hydrochloride) is a fixed-dose combination of empagliflozin (Jardiance), linagliptin (Tradjenta), and metformin hydrochloride indicated for the treatment of adults with type 2 diabetes.

Tazverik
Jan 24, 2020 - Tazverik (tazemetostat) is a methyltransferase inhibitor indicated for the treatment of patients with metastatic or locally advanced epithelioid sarcoma.

Ayvakit
Jan 23, 2020 - Ayvakit (avapritinib) is a potent and highly selective KIT and PDGFRα inhibitor for the treatment of PDGFRα Exon 18 mutant gastrointestinal stromal tumors (GIST) and fourth-line GIST.

Ubrelvy
Jan 1, 2020 - Ubrelvy (ubrogepant) is a CGRP receptor antagonist for the acute treatment of migraine.

Browse additions by year: